Prilenia indicators deal for former Teva ALS drug price as much as 500m
Israeli-Dutch scientific stage biotech firm Prilenia Therapeutics has introduced a collaboration and licensing settlement for its lead drug Pridopidine, ...
Thursday, May 22, 2025
Tag: Teva
Teva jumps sharply on bowel illness drug outcomes
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA share worth opened 20% increased on Wall Avenue after the Israeli ...
Teva reviews robust Q2 outcomes, raises 2024 forecast
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported robust outcomes for the second quarter of 2024 and once ...
Catalyst Pharmaceuticals: Until TEVA ANDA Is Resolved, There Is A Risk
JLGutierrez Here’s a company with one approved product in one rare disease, another product just approved and about to be ...
Teva once again most valuable company on TASE
After just over a year in the job, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Richard Francis ...
Tel Aviv stock indices fall, Teva Pharmaceuticals hits annual high By Investing.com
© Sivan Farag, Teva PR TEL AVIV - In the latest market movements on the Tel Aviv Stock Exchange, key ...
Corcept Therapeutics stock plunges after loss in patent battle with with Teva
Dr_Microbe/iStock via Getty Images Corcept Therapeutics (NASDAQ:CORT) plummeted 38% in after-hours trading on Friday after a loss in a patent ...
Teva teams with Sanofi on inflammatory bowel treatment
Israeli drug developer Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and French pharmaceutical company Sanofi (Nasdaq: SNY; Euronext: ...
Teva concludes US nationwide opioid settlement
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced the conclusion of a full resolution on its US ...
Teva misses on Q3 profit and revenue
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported results for the quarter ended September 30, 2022. Revenue for ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.